Mitsubishi Tanabe Pharma has recalled three lots of injected drugs made at its plant in Ashikaga, Japan after “some aspects of [quality] testing were inadequate.”
SurModics is still considering “strategic alternatives” for its pharmaceutical business, which has seen revenues continue to decline in the first quarter of 2011.
Oystar has sold its Brazilian unit, Oystar Fabrima, to Sao Paulo-headquartered firm Masipack in an effort to focus its business on country’s the primary and secondary packaging markets.
Pfizer’s Centres for Therapeutic Innovation (CTI) has teamed up with seven New York research hospitals to accelerate biomedical research into life-saving medicines, with a focus on biologics.
GSK and Teva will invest in Russian drug manufacturing in response to PM Vladimir Putin’s warning that Pharmas will face restrictions if they fail to boost local production and transfer technology.
PsiOxus Therapeutics has predicted growing demand for oncolytic vaccines, citing recent industry acquisitions as evidence of the need for novel treatments for cancer.
Contract Research Organisation (CRO) Quintiles has opened a Phase I facility in Hyderabad, India, citing increasing demand for efficiency in early-phase drug research in the country.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new job for former FDA chief and Catalent packaging appointments.
Hospira has confirmed it will no longer make Pentothal - an anaesthetic used in lethal injections – as the company “never condoned” its use in executions.
Baxter has shut down a production area at its plant in Castlebar, Ireland, telling the EMA it cannot guarantee peritoneal dialysis (PD) solutions made there are free of endotoxin contamination.
FedEx has launched a new shipping service for temperature sensitive products, specifically designed for customers in the life science and biopharma industries.
Contract Research Organisation (CRO) Calvert Labs has launched a new iPhone “app” that lets customers track the progress of preclinical research projects with their mobile phones.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at inVentiv, Icon, ICTS, OSO and Warnex.
The US FDA has suggested pharmaceutical firms use a maximum bead size of 2.0mm for modified-release drugs formulated for “sprinkle” delivery to avoid problems resulting from inadvertent chewing.
Cognizant will provide Eli Lilly with end-to-end IT services as part of a multi-year deal to help make Lilly’s US sales and marketing operations more effective, efficient and innovative.
Oncology registries may be ineffective for recruiting large, representative samples of adolescent cancer survivors to clinical trials, according to research.
One employee has died and two have been injured after an incident at Baxter International’s manufacturing facility in Atwater, California last weekend.
The US FDA has rejected MannKind’s inhaled insulin Afrezza and called for more clinical trials to prove the product’s “Dreamboat” delivery tech is comparable to the MedTone device used in earlier studies.
A magnetically controlled pill may boost the body’s absorption of drugs by safely securing the tablet at the right site in the gastrointestinal (GI) tract, say researchers at Brown University, US.
French contract research organisation (CRO) CIT will work on in vitro toxicity testing for pharmaceutical and cosmetic ingredients as the newest member of the European “ScreenTox” network.
US CMO Deltex Pharmaceuticals has been ordered to permanently halt manufacturing operations and recall all drugs it has distributed since October 2008, under a consent decree obtained by the FDA.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new job for former EMA chief and Catalent strengthening its production team.